Search Results for "Rna Interference Patents Dr Allen"

21:57 EDT 19th September 2014 | BioPortfolio

Original Source: Benitec - RNAi patent update

22 March 2011, Melbourne, Australia: Benitec Limited (ASX: BLT), a world leader in expressed gene silencing for human therapeutics, today announced further positive progress in its fundamental Graham family patent applications exclusively licensed from CSIRO worldwide for human therapeutics. These patents cover silencing of genes using DNA-directed RNA interference (ddRNAi). Progress on these patent applications further strengthens Benitec’s position with regards to both its revenue opportunities...

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Winscribe Names Greg Allen as CEO

Auckland, NZ (PRWEB) August 29, 2014 The Winscribe Board of Directors today announced the promotion of Greg Allen to Chief Executive Officer effective from 1st September 2014. Allen previously held...

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

Genticel granted five new patents in the US and Asia during first half of 2014

Genticel has been granted five patents in major territories since the beginning of 2014. These patents consolidate Genticel’s product pipeline in important emerging and mature pharmaceutical markets...

Allen Institute for Brain Science welcomes visiting scientist engineer

The Allen Institute for Brain Science welcomes a visiting scientist from Harvard and a visiting engineer from Georgia Tech: Sharad Ramanathan, Ph.D.; and Craig Forest, Ph.D. Both Ramanathan and Forest...

Allen, Texas - Texas Health Allen Earns Re-designation as 'Baby-Friendly'

Texas Health Presbyterian Hospital Allen was recently re-designated by the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) as a "Baby-Friendly Hospi...

Sun Diagnostics: Advancing Laboratory Medicine and Improving Healthcare

Sun Diagnostics, LLC continues to simplify interference testing with the release of ASSURANCE™ RF Interference Test Kit Sun Diagnostics, LLC announces the release of AS...

Topoisomerase II mediates meiotic crossover interference

Topoisomerase II mediates meiotic crossover interference by adjusting the protein/DNA meshwork of chromosome axes.

Ryogen awarded two patents directed to polynucleotide sequences

Ryogen, an R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded two new patents this month, bringing the total number of its issued U.S. Patents to 32.

Matching PubMed Articles

Patents: a tool to bring innovation from the lab bench to the marketplace.

Intellectual property (IP) is creations of the mind. Protecting IP through patents is an important venue for a researcher to reap rewards from his scientific endeavors. It is part of a competitive str...

Reviews Of Acoustical Patents.

The purpose of these acoustical patent reviews is to provide enough information for a Journal reader to decide whether to seek more information from the patent itself. Any opinions expressed here are ...

Dendritic Cell Vaccine and Cancer Treatment: New Patents.

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, th...

The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design.

The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is provided by licensed organizations that have the permission to use the Allen Carr method. However, few d...

Peptide nucleic acids: a review on recent patents and technology transfer.

Introduction: DNA/RNA-based drugs are considered of major interest in molecular diagnosis and nonviral gene therapy. In this field, peptide nucleic acids (PNAs, DNA analogs in which the sugar-phosphat...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement